Nuwellis (NUWE) Capital Expenditures Growth (5y) (2016 - 2026)
Nuwellis (NUWE) Capital Expenditures Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Nuwellis | 204,804.59 | -3.72 Mn | 1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.70% |
| Mar 31, 2026 | -11.74% |
| Dec 31, 2025 | -16.35% |
| Sep 30, 2025 | -6.62% |
| Jun 30, 2025 | -40.13% |
| Dec 31, 2024 | -2.42% |
| Sep 30, 2024 | -15.46% |
| Jun 30, 2024 | -27.15% |
| Mar 31, 2024 | -6.69% |
| Dec 31, 2023 | -30.01% |
| Sep 30, 2023 | 16.66% |
| Jun 30, 2023 | -4.44% |
| Mar 31, 2023 | -25.59% |
| Dec 31, 2022 | -18.55% |
| Sep 30, 2022 | -34.75% |
| Jun 30, 2022 | -11.27% |
| Dec 31, 2021 | 15.76% |
| Sep 30, 2021 | -34.33% |
| Jun 30, 2021 | 30.99% |
| Mar 31, 2021 | 47.58% |